This is a medical education non-promotional program for healthcare professionals sponsored by Sanofi and Regeneron.
In this educational symposium from the National Conference on Pediatric Health Care (NAPNAP) 2025, Jonathan Spergel, Wanda Phipatanakul, and Jerry Ellen Schonfeld investigate the role of Type 2 inflammation in pediatric diseases.1 The speakers discuss the difficulties in diagnosis and the burdens that patients and their families face.
Learning Objectives:
- Describe Type 2 inflammation and its role in multiple atopic diseases seen in pediatric patients
- Discuss the clinical presentation and clinical outcomes of various Type 2 inflammatory diseases, and the importance of prompt diagnosis
- Understand how multimorbidity impacts patient care and contributes to patient and caregiver burden
Speakers:
Jonathan Spergel1
Wanda Phipatanakul2
Jerry Ellen Schonfeld3
1. The Children’s Hospital of Philadelphia, Pennsylvania, USA
2. Boston Children’s Hospital, Massachusetts, USA
3. Children’s Hospital of Orange County, California, USA
References
1. Advent. What do you want to know about type 2 inflammatory diseases? 2025. Available at: https://www.adventprogram.com/us. Last accessed: 14 July 2025.
